- Home
- BWMX vs AURA Comparison
BWMX vs AURA Comparison
Compare BWMX & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWMX
- AURA
- Stock Information
- Founded
- BWMX 1995
- AURA 2007
- Country
- BWMX Mexico
- AURA United States
- Employees
- BWMX N/A
- AURA N/A
- Industry
- BWMX Catalog/Specialty Distribution
- AURA Biotechnology: Pharmaceutical Preparations
- Sector
- BWMX Consumer Discretionary
- AURA Health Care
- Exchange
- BWMX Nasdaq
- AURA Nasdaq
- Market Cap
- BWMX 447.8M
- AURA 370.1M
- IPO Year
- BWMX N/A
- AURA 2021
- Fundamental
- Price
- BWMX $11.35
- AURA $5.67
- Analyst Decision
- BWMX Strong Buy
- AURA Strong Buy
- Analyst Count
- BWMX 1
- AURA 4
- Target Price
- BWMX $22.50
- AURA $22.75
- AVG Volume (30 Days)
- BWMX 16.3K
- AURA 398.3K
- Earning Date
- BWMX 04-24-2025
- AURA 03-24-2025
- Dividend Yield
- BWMX 12.10%
- AURA N/A
- EPS Growth
- BWMX N/A
- AURA N/A
- EPS
- BWMX 0.92
- AURA N/A
- Revenue
- BWMX $676,704,288.00
- AURA N/A
- Revenue This Year
- BWMX $8.79
- AURA N/A
- Revenue Next Year
- BWMX $6.14
- AURA N/A
- P/E Ratio
- BWMX $12.42
- AURA N/A
- Revenue Growth
- BWMX 8.39
- AURA N/A
- 52 Week Low
- BWMX $10.05
- AURA $5.53
- 52 Week High
- BWMX $20.36
- AURA $12.38
- Technical
- Relative Strength Index (RSI)
- BWMX 47.11
- AURA 28.14
- Support Level
- BWMX $11.23
- AURA $5.77
- Resistance Level
- BWMX $11.87
- AURA $6.46
- Average True Range (ATR)
- BWMX 0.41
- AURA 0.48
- MACD
- BWMX -0.01
- AURA -0.16
- Stochastic Oscillator
- BWMX 22.31
- AURA 6.36
About BWMX Betterware de Mexico S.A.P.I. de C.V.
Betterware de Mexico SAPI de CV is a direct-to-consumer selling company. The company operates through two business segments: the home organization products (Betterware segment or BWM segment) and the beauty and personal care products (B and PC) (JAFRA segment). The Betterware's segment is divided into different categories based on the type of products it sells and includes, kitchen and food preservation, home solutions, bathroom, laundry & cleaning, tech and mobility, and bedroom and wellness products. The JAFRA's segment is divided into fragrance, color, skincare, and toiletries products. The company generates a majority of its revenue from the Beauty and personal care (B&PC) (JAFRA segment). Geographically, key revenue for the company is derived from Mexico.
About AURA Aura Biosciences Inc.
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its lead candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.